HERBAL MONOGRAPHS SAW PALMETTO / 667androgen receptor in rat prostate. J Steroid Biochem 1984;
20:521-523.
Carraro J. Raynaud J, Koch G et al., Comparison of
phytotherapy (Permixon) with finasteride in the treatment of
benign prostate hyperplasia: a randomized international study of
1.098 patients. Prostate 1996 Oct;29(4):231-40.
Casarosa C. Cosci M, o di Coscio, Fratta M, (1988) Lack of
effects of a lyposterolic extract of Serenoa repens on plasma
levels of testosterone, follicle-stimulating hormone, luteinizing
hormone. Clin Ther 10:5.
DiSilverio F, D'Eramo GD, Lubrano C et al., Evidence that
Serenoa repens extract displays an anti-estrogenic activity in
prostatic tissue of benign prostatic hypertrophy patients. Eur
Urol 1992: 21:309.
DiSilverio F, D'Eramo G. Flammia GP et ah, Pharmacological
combinations in the treatment of benign prostatic hypertrophy. J
Urol (Paris) 1993a; 99:316-320.
Engelmann U. Phytopharmaka und Synthetika bei der
Behandlung der benignen Prostatahypertrophie. In: ZPT
18(0:13-19. 1997.
Gerber GS, Zagaja GP, Bales GT, et al., Saw Palmetto
(Seronoa repens) in men with lower urinary tract symptoms:
effects oh urodynamic parameters and voiding symptoms.
Urology 1998 Jun;51(6): 1003-7.
Goepel M. Hecker U, Krege S et al.. Saw Palmetto extracts
potently and noncompetitively inhibit human alpha 1-
adrenoceptors in vitro. Prostate 1999 Feb 15;38(3):208-I5.
Gutierrez M, Garcia De Boto MJ, Cantabrana B et al.,
Mechanisms involved in the spasmolytic effect of extracts from
Sabal serrulata fruit on smooth muscle. Gen Pharmacol 1996;
27:171-176.
Grasso M. Montesano A, Buonaguidi A et al.. Comparative
effects of alfuzosin versus Serenoa repens in the treatment of
symptomatic benign prostatic hyperplasia. Arch Esp Urol 1995
Jan-Feb;48( 1):97-103.
Gutierrez M, Hidalgo A & Cantabrana B, Spasmolytic activity
of a lipidic extract from Sabal serrulata fruits further study of
the mechanism underlying this activity. Planta Med 1996;
62:507-511.
Hansel R et al., (1964) Planta Med 12:169.
Hamischfeger G, Stolze H, (1989) Serenoa repens - Die
Sagezahnpalme. Z Phytother 10:71-76.
Koch E, (1995) Pharmakologie und Wirkmechanismen von
Extrakten aus Sabalfriichten (Sabal fructus): Brennesselwurzeln
(Urticae radix) und Kurbissamen (Cucurbitae peponis semen)
bei der Behandlung der benignen Prostatahyperplasie. In: Loew
D, Rietbrock N (Hrsg) Phytopharmaka in Forschung und
klinischer Anwendung. Steinkopff Verlag, Darmstadt, S 57-79.Mattei FM, Capone M, Acconia A, Medikamentose Therapie
der benignen Prostatahyperplasie mit einem Exktrakt der
Sagepalme. In: Therapiewoche Urologie, Nephrologie 2:346-350.
1990.
Miersch WDE, Benigne Prostatahyperplasie. In: DAZ
133(29):2653. 1993.
Nahrstedt A, (1993) Pflanzliche Urologica - eine kritische
Ubersicht. Pharm Z 138:1439-1450.
Niederprum HJ, Schweikert HU, Zanker KS, (1994) Testosteron
5D-reductase inhibition by free fatty acids from Sabal serrulata
fruits. Phytomedicine 1:127-133.
Plosker GL, Brogden RN, Serenoa repens (Permixon (R)): A
review of its pharmacological and therapeutic efficacy in benign
prostatic hyperplasia. In: Drugs & Aging 9(5):379-395. 1996.
Ravenna L et al., Effects of the lipidosterolic extract of Serenoa
repens (Permixon (R)) on human prostatic cell lines. In:
Prostate 29(4):219-230. 1996. ~~:..
Rhodes L, Primka RL, Berman CH, Vergult F. Gabriel M,
Pierre-Malice M, Gibelin B, Comparision of Finasteride
(Proscar(R)), a 5alpha-reductase inhibitor, and various
commercial plant extracts in in vitro and in vivo 5alpha
reductase inhibition. In: Prostate.
Schilcher H, (1987) Moglichkeiten und Grenzen der
Phytotherapie am Beispiel pflanzlicher Urologika. Urologe [B]
27:316-319.
Schilcher H, (1987) Pflanzliche Diuretika. Urologe [B]27:215-
-222.
Schilcher B, In: Schilcher H: Phytotherapie in der Urologie.
Hippokrates Verlag Stuttgart. 1992.
Shimada H et al., Biological active acylglycerides from the
berries of Saw Palmetto (Serenoa repens). In: JNP 60(4):417-
- Sultan C, Terraza A, Devillier C et al.. Inhibition of androgen
metabolism and binding by a liposterolic extract of 'Serenoa
repens E" in human foreskin fibroblasts. J Steroid Biochem
1984; 20:515-519.
Vacher P, Prevarskaya N, Skryma R et al., The lipidosterolic
extract from Serenoa repens interferes with prolactin receptor
signal transduction. J Biomed Sci 1995; 2:357-365.
Wagner H, Flachsbarth H, (1981) Planta Med 41:244.
Wichtl M, Pflanzliche Geriatrika. In: DAZ 132(30): 1576. 1992.
Further information in:
Hansel R, Keller K, Rimpler H, Schneider G (Hrsg.), Hagers
Handbuch der Pharmazeutischen Praxis, 5. Aufl., Bde 4-6>
(Drogen): Springer Verlag Berlin, Heidelberg, New York, 1992-
- Sultan C, Terraza A, Devillier C et al.. Inhibition of androgen
Madaus G, Lehrbuch der Biologischen Arzneimittel, Bde 1-3,
Nachdruck, Georg Olms Verlag Hildesheim 1979.
Schulz R, Hansel R, Rationale Phytotherapie, Springer Verlag
Heidelberg 1996.
Teuscher E, Biogene Arzneimittel, 5. Aufl., Wiss. Verlagsges.
Stuttgart 1997.
Wagner H, Wiesenauer M, Phytotherapie. Phytopharmaka und
pflanzliche Homoopathika, Fischer-Verlag, Stuttgart, Jena, New
York 1995.